Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
CNOOC
00883
5
SINOPEC CORP
00386
| (FY)Dec 31, 2025 | (Q6)Jun 30, 2025 | (FY)Dec 31, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash flow from operating activities | ||||||||||
| Earning before tax | -41.76%94.42M | ---- | 3.12%162.11M | ---- | 15.31%157.21M | ---- | 20.91%136.34M | ---- | 13.05%112.76M | ---- |
| Profit adjustment | ||||||||||
| Interest (income) - adjustment | 15.79%-3.15M | ---- | ---3.74M | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Impairment and provisions: | -24.33%6.14M | ---- | 116.33%8.12M | ---- | 64.32%3.75M | ---- | 459.12%2.28M | ---- | -150.20%-636K | ---- |
| -Impairment of goodwill | -82.41%277K | ---- | --1.58M | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| -Other impairments and provisions | -10.35%5.87M | ---- | 74.37%6.54M | ---- | 64.32%3.75M | ---- | 459.12%2.28M | ---- | ---636K | ---- |
| Revaluation surplus: | 29.48%-847K | ---- | -141.46%-1.2M | ---- | 146.05%2.9M | ---- | -180.10%-6.29M | ---- | 950.92%7.85M | ---- |
| -Other fair value changes | 29.48%-847K | ---- | -141.46%-1.2M | ---- | 146.05%2.9M | ---- | -180.10%-6.29M | ---- | 950.92%7.85M | ---- |
| Asset sale loss (gain): | -254.25%-236K | ---- | -86.95%153K | ---- | 204.42%1.17M | ---- | 301.04%385K | ---- | -46.96%96K | ---- |
| -Loss (gain) on sale of property, machinery and equipment | -254.25%-236K | ---- | -20.31%153K | ---- | -50.13%192K | ---- | 301.04%385K | ---- | -46.96%96K | ---- |
| -Loss (gain) from selling other assets | ---- | ---- | ---- | ---- | --980K | ---- | ---- | ---- | ---- | ---- |
| Depreciation and amortization: | 8.78%77.35M | ---- | 9.09%71.11M | ---- | 8.80%65.18M | ---- | 37.14%59.91M | ---- | 7.06%43.68M | ---- |
| -Amortization of intangible assets | -12.96%477K | ---- | -52.84%548K | ---- | 51.11%1.16M | ---- | -1.03%769K | ---- | 2.64%777K | ---- |
| Financial expense | -24.88%6.49M | ---- | 0.61%8.64M | ---- | 47.68%8.59M | ---- | 55.30%5.82M | ---- | -15.50%3.75M | ---- |
| Special items | -85.32%610K | ---- | 28.17%4.15M | ---- | -79.21%3.24M | ---- | 65.87%15.59M | ---- | 3,473.38%9.4M | ---- |
| Operating profit before the change of operating capital | -27.50%180.78M | ---- | 3.01%249.34M | ---- | 13.09%242.04M | ---- | 20.99%214.03M | ---- | 21.36%176.9M | ---- |
| Change of operating capital | ||||||||||
| Inventory (increase) decrease | 317.43%4.18M | ---- | -546.98%-1.92M | ---- | 135.86%430K | ---- | ---1.2M | ---- | ---- | ---- |
| Accounts receivable (increase)decrease | -425.74%-80.58M | ---- | 62.02%-15.33M | ---- | -1.83%-40.35M | ---- | -3,399.50%-39.63M | ---- | 107.36%1.2M | ---- |
| Accounts payable increase (decrease) | 273.32%23.56M | ---- | -38.70%6.31M | ---- | -14.39%10.3M | ---- | 206.19%12.03M | ---- | -230.87%-11.32M | ---- |
| prepayments (increase)decrease | -669.37%-29.84M | ---- | 74.76%-3.88M | ---- | -256.41%-15.37M | ---- | 241.76%9.82M | ---- | 41.88%-6.93M | ---- |
| Special items for working capital changes | -1,942.88%-15.2M | ---- | -116.67%-744K | ---- | 478.99%4.46M | ---- | 137.65%771K | ---- | -396.38%-2.05M | ---- |
| Cash from business operations | -64.54%82.9M | ---- | 16.01%233.78M | ---- | 2.91%201.52M | ---- | 24.10%195.82M | ---- | 24.39%157.8M | ---- |
| Other taxs | -27.97%-38.57M | ---- | -14.14%-30.14M | ---- | -35.71%-26.41M | ---- | 15.90%-19.46M | ---- | -102.46%-23.14M | ---- |
| Special items of business | ---- | -90.52%5.92M | ---- | 8.17%62.48M | ---- | 26.75%57.76M | ---- | -22.46%45.57M | ---- | 12.89%58.77M |
| Net cash from operations | -78.23%44.33M | -90.52%5.92M | 16.29%203.64M | 8.17%62.48M | -0.71%175.11M | 26.75%57.76M | 30.97%176.37M | -22.46%45.57M | 16.66%134.66M | 12.89%58.77M |
| Cash flow from investment activities | ||||||||||
| Interest received - investment | -15.79%3.15M | ---- | --3.74M | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Loan receivable (increase) decrease | ---- | ---- | 84.66%-1.22M | ---- | ---7.95M | ---- | ---- | ---- | ---- | ---- |
| Decrease in deposits (increase) | -155.47%-4.09M | ---- | 94.92%-1.6M | ---- | -5,919.41%-31.48M | ---- | 107.12%541K | ---- | ---7.6M | ---- |
| Sale of fixed assets | 105.00%4.1M | ---- | 27.70%2M | ---- | -42.05%1.57M | ---- | -52.97%2.7M | ---- | -18.08%5.75M | ---- |
| Purchase of fixed assets | -11.09%-74.48M | ---- | 17.73%-67.04M | ---- | -64.04%-81.49M | ---- | -9.99%-49.68M | ---- | -26.82%-45.17M | ---- |
| Acquisition of subsidiaries | ---330K | ---- | ---- | ---- | ---2.33M | ---- | ---- | ---- | 2.53%-8.79M | ---- |
| Recovery of cash from investments | -70.69%777K | ---- | 63.04%2.65M | ---- | 20.89%1.63M | ---- | 888.97%1.35M | ---- | -85.68%136K | ---- |
| Other items in the investment business | ---- | -21.85%-46.21M | ---- | 34.59%-37.93M | ---- | -107.49%-57.98M | 73.06%-1.96M | 19.23%-27.94M | ---7.26M | -164.64%-34.6M |
| Net cash from investment operations | -15.29%-70.86M | -21.85%-46.21M | 48.80%-61.46M | 34.59%-37.93M | -155.19%-120.06M | -107.49%-57.98M | 25.25%-47.05M | 19.23%-27.94M | -60.73%-62.93M | -164.64%-34.6M |
| Net cash before financing | -118.66%-26.53M | -264.07%-40.29M | 158.25%142.18M | 11,261.36%24.56M | -57.43%55.05M | -101.25%-220K | 80.29%129.32M | -27.07%17.63M | -5.97%71.73M | -38.00%24.17M |
| Cash flow from financing activities | ||||||||||
| New borrowing | 145.61%146.14M | ---- | -44.19%59.5M | ---- | 301.99%106.61M | ---- | -46.99%26.52M | ---- | -15.75%50.03M | ---- |
| Refund | 5.38%-55.81M | ---- | 30.07%-58.98M | ---- | -284.07%-84.34M | ---- | 67.60%-21.96M | ---- | 28.39%-67.77M | ---- |
| Issuing shares | 81.21%6.56M | ---- | 67.11%3.62M | ---- | --2.17M | ---- | ---- | ---- | --4.1M | ---- |
| Interest paid - financing | -43.16%-6.71M | ---- | 27.93%-4.69M | ---- | -24.04%-6.51M | ---- | 17.27%-5.25M | ---- | -17.19%-6.34M | ---- |
| Dividends paid - financing | -294.00%-36.21M | ---- | 66.41%-9.19M | ---- | -46.16%-27.36M | ---- | 32.85%-18.72M | ---- | -69.96%-27.87M | ---- |
| Absorb investment income | ---- | ---- | --323K | ---- | ---- | ---- | ---- | ---- | 162.46%6.1M | ---- |
| Issuance expenses and redemption of securities expenses | 58.72%-28.61M | ---- | ---69.3M | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Other items of the financing business | -182.90%-62.71M | 63.50%-21.87M | -52.73%-22.17M | -471.99%-59.9M | -255.30%-14.51M | -265.29%-10.47M | 35.25%-4.09M | -84.69%6.34M | -6.57%-6.31M | 845.11%41.39M |
| Net cash from financing operations | 31.20%-63.95M | 63.50%-21.87M | -131.99%-92.96M | -471.99%-59.9M | -8.38%-40.07M | -265.29%-10.47M | -99.90%-36.97M | -84.69%6.34M | 74.18%-18.5M | 845.11%41.39M |
| Effect of rate | 216.14%10.72M | 1,162.68%10.85M | 7.56%-9.23M | -144.68%-1.02M | 51.81%-9.99M | -73.86%2.29M | -663.77%-20.73M | 674.38%8.74M | -14.05%3.68M | 5.17%-1.52M |
| Net Cash | -283.84%-90.49M | -75.83%-62.15M | 228.46%49.22M | -230.58%-35.35M | -83.77%14.99M | -144.62%-10.69M | 73.48%92.35M | -63.45%23.96M | 1,047.76%53.23M | 96.12%65.56M |
| Begining period cash | 17.60%267.24M | 17.60%267.24M | 2.25%227.25M | 2.25%227.25M | 47.54%222.25M | 47.54%222.25M | 60.72%150.64M | 90.98%150.64M | 10.51%93.73M | 3.77%78.88M |
| Cash at the end | -29.85%187.47M | 13.12%215.93M | 17.60%267.24M | -10.74%190.88M | 2.25%227.25M | 16.64%213.85M | 47.54%222.25M | 28.29%183.34M | 60.72%150.64M | 32.53%142.92M |
| Cash balance analysis | ||||||||||
| Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
| Accounting Standards | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS |
| Audit Opinions | -- | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- |
| Auditor | -- | -- | Ernst & Young | -- | Ernst & Young | -- | Ernst & Young | -- | Deloitte Touche Tohmatsu Limited | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.